# Effects of Transversus Abdominis Plane Block on Recovery Quality and Maternal-Neonatal Outcomes After Cesarean Delivery

> **NCT07478692** · NA · COMPLETED · sponsor: **Qing Yuan** · enrollment: 83 (actual)

## Conditions studied

- Postoperative Pain After Cesarean Section

## Interventions

- **DRUG:** The TAP block group received ultrasound-guided bilateral TAP block (20 mL of 0.375 % ropivacaine per side) during surgery and postoperative intravenous analgesia pump (formula of butorphanol 2 mg/kg)

## Key facts

- **NCT ID:** NCT07478692
- **Lead sponsor:** Qing Yuan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-01
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07478692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07478692, "Effects of Transversus Abdominis Plane Block on Recovery Quality and Maternal-Neonatal Outcomes After Cesarean Delivery". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT07478692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*